Quadriga BioSciences Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Private

  • Employees
  • 5

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 2

Quadriga BioSciences General Information

Description

Developer of proprietary targeted cancer therapies designed to offer personalized medicine for cancer treatment. The company develops novel targeted molecules against cancer cells that overexpress certain unique amino acid transporters on their cell surface for the intake of nutrients to support rapid tumor growth and proliferation, enabling professionals to deliver safe and effective treatments for patients with cancer.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 95 Main Street
  • Suite 9
  • Los Altos, CA 94022
  • United States
+1 (650)
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Vertical(s)
Corporate Office
  • 95 Main Street
  • Suite 9
  • Los Altos, CA 94022
  • United States
+1 (650)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Quadriga BioSciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Secondary Transaction - Private 01-Mar-2026 Completed Clinical Trials - Phase 1
8. Grant 01-Sep-2021 Completed Clinical Trials - Phase 1
7. Grant 01-Sep-2021 Completed Clinical Trials - Phase 1
6. Later Stage VC (Series A) 20-Oct-2017 Completed Generating Revenue
5. Grant 01-Jan-2017 Completed Generating Revenue
4. Seed Round 05-Feb-2015 Completed Startup
3. Grant 01-Jun-2013 Completed Startup
2. Grant 01-Jun-2013 $288K Completed Startup
1. Debt - General Completed Startup
To view Quadriga BioSciences’s complete valuation and funding history, request access »

Quadriga BioSciences Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
Series A-2
Series A-1 1,741,234 $0.002000 $0.17 $2.14 $2.14 1x $2.14 0%
Seed 901,904 $0.002000 $1.4 $1.4 1x $1.4 8.94%
To view Quadriga BioSciences’s complete cap table history, request access »

Quadriga BioSciences Patents

Quadriga BioSciences Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2022206282-A1 Pharmaceutical compositions of chemotherapeutic agents based on beta-substituted beta-amino acid derivatives Active 08-Jan-2021
AU-2022206282-A9 Pharmaceutical compositions of chemotherapeutic agents based on beta-substituted beta-amino acid derivatives Active 08-Jan-2021
AU-2022206282-B2 Pharmaceutical compositions of chemotherapeutic agents based on beta-substituted beta-amino acid derivatives Active 08-Jan-2021
AU-2024264662-A1 Pharmaceutical compositions of chemotherapeutic agents based on beta-substituted beta-amino acid derivatives Active 08-Jan-2021
AU-2024264662-B2 Pharmaceutical compositions of chemotherapeutic agents based on beta-substituted beta-amino acid derivatives Active 08-Jan-2021 C08B37/0015
To view Quadriga BioSciences’s complete patent history, request access »

Quadriga BioSciences Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Quadriga BioSciences Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
National Institutes of Health Government
National Cancer Institute Government
To view Quadriga BioSciences’s complete investors history, request access »

Quadriga BioSciences FAQs

  • When was Quadriga BioSciences founded?

    Quadriga BioSciences was founded in 2010.

  • Where is Quadriga BioSciences headquartered?

    Quadriga BioSciences is headquartered in Los Altos, CA.

  • What is the size of Quadriga BioSciences?

    Quadriga BioSciences has 5 total employees.

  • What industry is Quadriga BioSciences in?

    Quadriga BioSciences’s primary industry is Biotechnology.

  • Is Quadriga BioSciences a private or public company?

    Quadriga BioSciences is a Private company.

  • What is Quadriga BioSciences’s current revenue?

    The current revenue for Quadriga BioSciences is .

  • How much funding has Quadriga BioSciences raised over time?

    Quadriga BioSciences has raised $9M.

  • Who are Quadriga BioSciences’s investors?

    National Institutes of Health and National Cancer Institute have invested in Quadriga BioSciences.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process